AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 80 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $44,000 | -71.8% | 223,500 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $156,000 | -43.3% | 223,500 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $275,000 | -21.2% | 223,500 | +19.2% | 0.00% | -25.0% |
| Q1 2017 | $349,000 | -64.1% | 187,500 | 0.0% | 0.00% | -69.2% |
| Q4 2016 | $971,000 | – | 187,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 128,000 | $142,000 | 0.10% |
| Baker Brothers Advisors | 4,055,142 | $4,501,000 | 0.03% |
| WEDBUSH SECURITIES INC | 209,524 | $233,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,500,000 | $6,105,000 | 0.01% |
| Verity Asset Management, Inc. | 11,500 | $13,000 | 0.01% |
| OneDigital Investment Advisors LLC | 11,437 | $13,000 | 0.00% |
| HYMAN CHARLES D | 15,143 | $17,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 120,619 | $134,000 | 0.00% |
| Legacy Advisors, LLC | 2,450 | $3,000 | 0.00% |
| Kavar Capital Partners, LLC | 1,500 | $2,000 | 0.00% |